Endocyte Reports First Quarter Financial Results and Provides Clinical and Pipeline Update
May 10, 2017 08:00 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., May 10, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
Endocyte Announces First Quarter 2017 Earnings Conference Call
May 03, 2017 16:01 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., May 03, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc., (NASDAQ:ECYT) announced today that the company will host a conference call on Wednesday, May 10th, at 8:30 a.m. EDT to discuss...
Endocyte Presents Data at AACR Identifying Multiple Methods for Managing Severe Side Effects Resulting from CAR T-Cell Treatment
April 05, 2017 08:00 ET
|
Endocyte, Inc.
- Late-breaking poster demonstrates that Endocyte’s bi-specific adaptor molecules can mitigate or eliminate cytokine storms - - Potential to meaningfully improve the safety and tolerability of CAR...
Endocyte Announces Presentations at American Association for Cancer Research (AACR) Annual Meeting 2017
March 27, 2017 16:01 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., March 27, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
Endocyte Reports Fourth Quarter and Year End 2016 Financial Results and Provides Clinical and Pipeline Update
March 10, 2017 08:05 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., March 10, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
Endocyte and Seattle Children’s Research Institute to Collaborate on Endocyte’s Small Molecule Drug Conjugate Bi-Specific Adaptor Molecules for CAR T-cell Therapies
March 10, 2017 08:00 ET
|
Endocyte, Inc.
Collaboration pairs leading SMDC technology with recognized CAR T-cell research expert Plans to develop next generation CAR T-cell therapeutic platform with potential for improved safety and...
Endocyte Announces Fourth Quarter and Full Year 2016 Earnings Conference Call
March 02, 2017 08:00 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., March 02, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc., (NASDAQ:ECYT) announced today that the company will host a conference call on Friday, March 10th, at 8:30 a.m. EST to discuss...
Endocyte to Present at the Cowen and Company 37th Annual Health Care Conference
March 01, 2017 16:01 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., March 01, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
Endocyte Appoints Michael T. Andriole as Chief Financial Officer
February 21, 2017 08:00 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., Feb. 21, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
Endocyte to Present at the IASLC 17th World Conference on Lung Cancer
December 01, 2016 08:01 ET
|
Endocyte, inc
WEST LAFAYETTE, Ind., Dec. 01, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...